Aandeel JULPHAR GULF PHARMACEUTICAL INDUSTRIES
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Gulf Pharmaceutical Industries

Aandelen

JULPHAR

AEG000201018

Beurs gesloten - Abu Dhabi Securities Exchange
Andere beurzen
 12:29:02 19-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,96 AED -0,41% Intraday-grafiek van Gulf Pharmaceutical Industries -4,00% +24,84%
15/03 Gulf Pharmaceutical Industries' FY23 toerekenbaar verlies neemt toe; inkomsten stijgen MT
13/02 Gulf Pharmaceutical Industries P.S.C. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Gulf Pharmaceutical Industries Shares to be Suspended Ahead of Annual General Meeting
Abu Dhabi's Gulf Pharmaceutical Industries Resumes Trading Following FY23 Results Publication
Gulf Pharmaceutical Industries' FY23 Attributable Loss Widens; Revenue Up
Gulf Pharmaceutical Industries to Halt Trading During Board Meeting
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2023
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the First Quarter Ended March 31, 2023
Gulf Pharmaceutical Industries P.S.C. Approves Board Appointments
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2022
Gulf Pharmaceutical Industries P.S.C. Announces Chief Executive Officer Changes
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Gulf Pharmaceutical Industries P.S.C. Announces Resignation of Sanjay Deshmukh as Chief Operating Officer
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Cigalah Group completed the acquisition of 51% stake in Alpha Pharma L.L.C. from Gulf Pharmaceutical Industries P.S.C..
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the First Quarter Ended March 31, 2022
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2021
Gulf Pharmaceutical Industries Announces the Resignation of Ragheb Alshakhshir as Chief Scientific Officer
Quantum Genomics Société Anonyme Signs an Exclusive License and Production Agreement with Gulf Pharmaceuticals Industries Julphar
Quantum Genomics Société Anonyme announced that it expects to receive $2 million in funding from Gulf Pharmaceutical Industries P.S.C.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers JULPHAR
  4. Nieuws Gulf Pharmaceutical Industries
  5. Andere talen